{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:57:34Z","timestamp":1790899054162,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32281-7","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T18:04:03Z","timestamp":1765476243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Remnant cholesterol inflammatory index and cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhuojing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juzi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"32281_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele, C. E. et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: A scientific statement from the American heart association. Circulation 148, 1636\u20131664 (2023).","journal-title":"Circulation"},{"key":"32281_CR2","doi-asserted-by":"crossref","unstructured":"Mutruc, V. et al. Cardiovascular-Kidney-Metabolic syndrome: A new paradigm in clinical medicine or going back to basics? J. Clin. Med. 14 (2025).","DOI":"10.3390\/jcm14082833"},{"key":"32281_CR3","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","volume":"8","author":"JW Ostrominski","year":"2023","unstructured":"Ostrominski, J. W. et al. Prevalence and overlap of cardiac, renal, and metabolic conditions in US Adults, 1999\u20132020. JAMA Cardiol. 8, 1050\u20131060 (2023).","journal-title":"JAMA Cardiol."},{"key":"32281_CR4","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jacc.2024.03.368","volume":"83","author":"AMK Minhas","year":"2024","unstructured":"Minhas, A. M. K. et al. Prevalence of the cardiovascular-kidney-metabolic syndrome in the United States. J. Am. Coll. Cardiol. 83, 1824\u20131826 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"32281_CR5","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal, R., Ostrominski, J. W. & Vaduganathan, M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 331, 1858\u20131860 (2024).","journal-title":"JAMA"},{"key":"32281_CR6","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","volume":"42","author":"R Quispe","year":"2021","unstructured":"Quispe, R. et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and apob: a primary prevention study. Eur. Heart J. 42, 4324\u20134332 (2021).","journal-title":"Eur. Heart J."},{"key":"32281_CR7","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1161\/ATVBAHA.123.319297","volume":"43","author":"EP Navarese","year":"2023","unstructured":"Navarese, E. P. et al. Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: A Mendelian randomization study. Arterioscler. Thromb. Vasc. Biol. 43, e373\u2013e380 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"32281_CR8","doi-asserted-by":"publisher","first-page":"1429993","DOI":"10.3389\/fcvm.2024.1429993","volume":"11","author":"X Li","year":"2024","unstructured":"Li, X., Hu, J. G., Liao, Q., Wu, Y. & Huo, R. R. Triglyceride-glucose index mediates the association between residual cholesterol and stroke among middle-aged and older adults in china: a prospective, nationwide, population-based study. Front. Cardiovasc. Med. 11, 1429993 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"32281_CR9","doi-asserted-by":"crossref","unstructured":"Ding, X., Tian, J., Chang, X., Liu, J. & Wang, G. Association between remnant cholesterol and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study. Eur. J. Prev. Cardiol (2025).","DOI":"10.1093\/eurjpc\/zwaf248"},{"key":"32281_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/MOL.0000000000000921","volume":"35","author":"P Raggi","year":"2024","unstructured":"Raggi, P., Becciu, M. L. & Navarese, E. P. Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events. Curr. Opin. Lipidol. 35, 110\u2013116 (2024).","journal-title":"Curr. Opin. Lipidol."},{"key":"32281_CR11","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/eurheartj\/ehac822","volume":"44","author":"BN Wadstr\u00f6m","year":"2023","unstructured":"Wadstr\u00f6m, B. N., Pedersen, K. M., Wulff, A. B. & Nordestgaard, B. G. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur. Heart J. 44, 1432\u20131445 (2023).","journal-title":"Eur. Heart J."},{"key":"32281_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12944-025-02580-z","volume":"24","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese National population surveys. Lipids Health Dis. 24, 155 (2025).","journal-title":"Lipids Health Dis."},{"key":"32281_CR13","doi-asserted-by":"crossref","unstructured":"Chen, J. et al. Predictive value of remnant cholesterol inflammatory index for stroke risk: evidence from the China health and retirement longitudinal study. J. Adv. Res. (2024).","DOI":"10.1016\/j.jare.2024.12.015"},{"key":"32281_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y., Hu, Y., Smith, J. P., Strauss, J. & Yang, G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int. J. Epidemiol. 43, 61\u201368 (2014).","journal-title":"Int. J. Epidemiol."},{"key":"32281_CR15","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele, C. E. et al. Cardiovascular-kidney-metabolic health: A presidential advisory from the American heart association. Circulation 148, 1606\u20131635 (2023).","journal-title":"Circulation"},{"key":"32281_CR16","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He, D. et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur. Heart J. 45, 1058\u20131068 (2024).","journal-title":"Eur. Heart J."},{"key":"32281_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12933-024-02485-8","volume":"23","author":"X Zheng","year":"2024","unstructured":"Zheng, X. et al. Changes in the estimated glucose disposal rate and incident cardiovascular disease: two large prospective cohorts in Europe and Asia. Cardiovasc. Diabetol. 23, 403 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"32281_CR18","doi-asserted-by":"crossref","unstructured":"Kraaijenhof, J. M. et al. The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study. Eur J. Prev. Cardiol. (2025).","DOI":"10.1093\/eurjpc\/zwaf037"},{"key":"32281_CR19","doi-asserted-by":"publisher","first-page":"119048","DOI":"10.1016\/j.atherosclerosis.2024.119048","volume":"401","author":"H Drexel","year":"2025","unstructured":"Drexel, H. et al. Remnant cholesterol and long-term incidence of death in coronary artery disease patients. Atherosclerosis 401, 119048 (2025).","journal-title":"Atherosclerosis"},{"key":"32281_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/eurjpc\/zwae102","volume":"31","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. The role of remnant cholesterol in patients with ST-segment elevation myocardial infarction. Eur. J. Prev. Cardiol. 31, 1227\u20131237 (2024).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"32281_CR21","doi-asserted-by":"publisher","first-page":"1604284","DOI":"10.3389\/fcvm.2025.1604284","volume":"12","author":"W Luo","year":"2025","unstructured":"Luo, W. et al. The association between triglyceride-glucose index, atherogenic index of plasma, systemic immune-inflammation index, and mortality in patients with acute coronary syndrome: the direct effects of glucose-lipid metabolism and U-shaped immune modulation in mortality risk. Front. Cardiovasc. Med. 12, 1604284 (2025).","journal-title":"Front. Cardiovasc. Med."},{"key":"32281_CR22","doi-asserted-by":"publisher","first-page":"1618157","DOI":"10.3389\/fendo.2025.1618157","volume":"16","author":"PA Lian","year":"2025","unstructured":"Lian, P. A. et al. Association of the atherogenic index of plasma and high-sensitivity C-reactive protein with incident cardiovascular disease: evidence from a National cohort of middle-aged and older Chinese adults. Front. Endocrinol. (Lausanne). 16, 1618157 (2025).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"32281_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13098-025-01882-7","volume":"17","author":"J Chen","year":"2025","unstructured":"Chen, J., Yan, L., He, L. & Wang, W. Association between different dimensions of the C-reactive protein-triglyceride-glucose index and future cardiovascular disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide cohort study. Diabetol. Metab. Syndr. 17, 299 (2025).","journal-title":"Diabetol. Metab. Syndr."},{"key":"32281_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-024-02571-x","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang, Y. et al. Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovasc. Diabetol. 24, 11 (2025).","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32281-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32281-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32281-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:09:26Z","timestamp":1769213366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32281-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32281"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32281-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in this study were approved by the Biomedical Ethics Review Board of Peking University (approval number: IRB00001052-11015). Written informed consent was gained from all participants. All human research methods described in the manuscript were in accordance with national laws and the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2498"}}